VACCINATION

New figures from the World Health Organization and the Centers for Disease Control and Prevention.

Urgent action is needed to ensure that critical medical innovations reach the people that need them.

Last month AstraZeneca paused its trial of another vaccine candidate.

Small phase 1 trial demonstrates safety and immunogenicity of SARS-CoV-2 mRNA-1273 vaccine in older adults.

The effect of COVID-19 physical distancing measures on childhood vaccination counts in England.

Lancet study finds signs that public trust in vaccine safety is increasing.

But is as low as 19 per cent in other countries.

At 35 days, the vaccine induced high immune responses and appeared to be safe.

Antigen-specific antibody decay kinetics and HIV-1 vaccine design

Countries supported by the Vaccine Alliance have higher vaccination rates, but COVID-19 is endangering efforts.

The College has developed guidance for GP practices to support the delivery of vaccination programmes while COVID-19 remains a threat.

Around 30 million people in England will be eligible to receive it.

The number of cases of invasive meningococcal disease dropped by 12 per cent in Q1 2020 compared with Q1 2019.

Figures from Public Health England for the period from January to March 2020.